Stopping Prostate Cancer A New Look
Researchers from Massachusetts General Harvard, Dana Farber Cancer Institute and Brigham and Women’s Hospital recently revealed that long-term use of aspirin is associated with lower risk of dying from various types of cancers, including lung and prostate cancer. Both cancers are the leading killers of men. The findings were presented at the April 2017 meeting of the American Association for Cancer Research.
Apparently aspirin not only reduces the risk of developing cancer, but may also play a strong role in reducing death from cancer,” according to Yin Cao, the lead author of the study and an instructor Massachusetts General Hospital and Harvard Medical School.
Reductions in overall mortality risks from cancer were noted at dosages ranging from half a standard aspirin tablet per week to seven tablets weekly.
(NOTE : The study did not report aspirin having a positive impact on benign prostatic hyperplasia (BPH). Ninety percent of all men show signs of such prostatic enlargement by the age of 80. BPH can often mimic Prostate Cancer symptoms and can include difficulty in starting urination, a diminished force of urinary stream, a sensation of fullness in the bladder after urination, and the need to urinate many times at night. Untreated BPH can become so severe that urination is impossible).
The study found that women who took aspirin were also at a 11 percent lower risk of dying from breast cancer. Men who took aspirin had a 23 percent lower risk of dying from prostate cancer.
Although aspirin has been shown to reduce the risk of heart disease and strokes, daily use is known to increase the likelihood of gastrointestinal bleeding.
As always speak up, talk to your physicians and make informed decisions when it comes to your health.
When it comes to Prostate Cancer – Silence Is Not A Cure